Camber Capital Management

Camber Capital Management as of March 31, 2017

Portfolio Holdings for Camber Capital Management

Camber Capital Management holds 31 positions in its portfolio as reported in the March 2017 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Spdr S&p 500 Etf (SPY) 28.8 $707M 3.0M 235.74
Gilead Sciences (GILD) 8.0 $197M 2.9M 67.92
Teva Pharmaceutical Industries (TEVA) 6.8 $167M 5.2M 32.09
Mylan Nv 6.6 $162M 4.1M 38.99
Nektar Therapeutics (NKTR) 5.2 $127M 5.4M 23.47
Allergan 4.2 $104M 436k 238.92
Myriad Genetics (MYGN) 3.4 $83M 4.3M 19.20
Genomic Health 3.1 $77M 2.5M 31.49
Brookdale Senior Living (BKD) 3.0 $74M 5.5M 13.43
Vertex Pharmaceuticals Incorporated (VRTX) 2.9 $71M 650k 109.35
Select Medical Holdings Corporation (SEM) 2.7 $67M 5.0M 13.35
Bioverativ Inc Com equity 2.4 $60M 1.1M 54.46
Livanova Plc Ord (LIVN) 2.4 $59M 1.2M 49.01
Orthofix International Nv Com Stk 2.3 $57M 1.5M 38.15
Endo International (ENDPQ) 2.3 $56M 5.1M 11.16
Perrigo Company (PRGO) 2.2 $54M 808k 66.39
Cardiovascular Systems 2.0 $50M 1.8M 28.27
Abbott Laboratories (ABT) 1.8 $44M 1.0M 44.41
Endologix 1.8 $43M 6.0M 7.24
Alkermes (ALKS) 1.7 $42M 725k 58.50
Sarepta Therapeutics (SRPT) 1.6 $40M 1.4M 29.60
Invitae (NVTA) 1.1 $27M 2.4M 11.06
Syneron Medical Ltd ord 1.0 $25M 2.3M 10.55
Puma Biotechnology (PBYI) 1.0 $24M 650k 37.20
BioScrip 0.7 $17M 10M 1.70
Ptc Therapeutics I (PTCT) 0.5 $12M 1.3M 9.84
Arena Pharmaceuticals 0.2 $6.2M 4.3M 1.46
Atara Biotherapeutics (ATRA) 0.1 $2.6M 125k 20.55
Targacept Inc Conv Dtd convertible 0.1 $1.7M 1.7M 1.00
Dextera Surgical 0.0 $888k 838k 1.06
Biolase Technology 0.0 $0 7.2M 0.00